Published in Indian J Surg Oncol on February 18, 2012
Usefulness of positron emission tomography-computed tomography in pre-operative evaluation of intra-thoracic esophageal cancer. Thorac Cancer (2015) 0.81
Role of Pre-therapeutic (18)F-FDG PET/CT in Guiding the Treatment Strategy and Predicting Prognosis in Patients with Esophageal Carcinoma. Asia Ocean J Nucl Med Biol (2016) 0.75
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol (2001) 6.07
Cancer statistics, 1993. CA Cancer J Clin (1993) 3.43
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer (2005) 1.64
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg (1988) 1.54
PET imaging in oncology. Semin Nucl Med (2000) 1.42
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40
Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res (2007) 1.31
Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. AJR Am J Roentgenol (1990) 1.26
Role of EUS. Gastrointest Endosc (2007) 1.23
Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg (2007) 1.20
Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18
The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc (2007) 1.15
Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med (2000) 1.11
Epidemiology of cancer of the esophagus. Semin Oncol (1984) 1.09
Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med (2004) 1.04
Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology (1989) 1.02
Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer (1999) 1.00
Diagnosis and treatment of early esophageal cancer. Curr Opin Gastroenterol (2006) 0.95
Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer. Eur Radiol (2010) 0.92
Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surg Oncol (2001) 0.92
Certain mortality patterns of esophageal cancer in the United States, 1930-67. J Natl Cancer Inst (1971) 0.91
Upper gastrointestinal tract tumours: diagnosis and staging strategies. Cancer Imaging (2005) 0.91
Endoscopic ultrasound for preoperative staging of esophageal carcinoma. Surg Endosc (2005) 0.91
Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med (2009) 0.91
Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Surg Laparosc Endosc (1997) 0.91
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma. Clin Radiol (2008) 0.87
Epidemiology of cancer of the esophagus in Canada: 1931-1984. Gastroenterology (1988) 0.86
Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg (2004) 0.86
Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol (2003) 0.84
Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy. World J Gastroenterol (2009) 0.84
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. J Gastroenterol Hepatol (2004) 1.96
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. J Nucl Med (2013) 1.17
Potential role of 18F-FDG PET/CT in patients with fungal infections. AJR Am J Roentgenol (2014) 1.14
Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur Radiol (2011) 1.10
Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma. Eur J Nucl Med Mol Imaging (2013) 1.07
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid (2013) 1.07
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan. Jpn J Radiol (2013) 1.02
Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management. Nucl Med Commun (2012) 1.01
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial. Radiology (2007) 1.00
SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy. Diagn Interv Radiol (2013) 0.97
99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteoma. Nucl Med Commun (2014) 0.94
(177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study. Eur J Nucl Med Mol Imaging (2014) 0.92
Detection of recurrent cutaneous angiosarcoma of lower extremity with (18)f-fluorodeoxyglucose positron emission tomography-computed tomography: report of three cases. Indian J Dermatol (2013) 0.92
Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Eur J Nucl Med Mol Imaging (2013) 0.91
Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin. AJR Am J Roentgenol (2012) 0.91
Renal and hematological toxicity in patients of neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-DOTATATE. Cancer Biother Radiopharm (2012) 0.91
The predictive role of 24h RAIU with respect to the outcome of low fixed dose radioiodine therapy in patients with diffuse toxic goiter. Hormones (Athens) (2013) 0.90
Radioiodine avid axillary lymph node metastasis in papillary thyroid cancer: report of a case. Indian J Surg Oncol (2011) 0.90
Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT. Clin Nucl Med (2015) 0.88
Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes. Clin Nucl Med (2015) 0.88
Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review. Acta Radiol (2013) 0.88
Utility of (99m)Tc-MDP hybrid SPECT-CT for diagnosis of skull base osteomyelitis: comparison with planar bone scintigraphy, SPECT, and CT. Jpn J Radiol (2012) 0.87
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2013) 0.86
Detection of brain metastasis with 68Ga-labeled PSMA ligand PET/CT: a novel radiotracer for imaging of prostate carcinoma. Clin Nucl Med (2015) 0.86
Utility of (99m)Tc-MDP SPECT-CT for the diagnosis of sesamoiditis as cause of metatarsalgia. Indian J Nucl Med (2012) 0.86
Inguinal node metastasis from follicular thyroid cancer. Indian J Endocrinol Metab (2013) 0.86
Metabolic Skeletal Superscan on 18F-FDG PET/CT in a Case of Acute Lymphoblastic Leukemia. Clin Nucl Med (2015) 0.85
Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT. Clin Nucl Med (2012) 0.85
Solid variant of papillary carcinoma thyroid in a child with no history of radiation exposure. Indian J Nucl Med (2011) 0.84
Hybrid SPECT-CT for characterizing isolated vertebral lesions observed by bone scintigraphy: comparison with planar scintigraphy, SPECT, and CT. Diagn Interv Radiol (2012) 0.84
Vicarious visualization of gall bladder on Tc-99m ethylene dicysteine renal dynamic study. Indian J Nucl Med (2012) 0.83
Peptide receptor radionuclide therapy with (177)Lu DOTATATE in a case of recurrent carotid body paraganglioma with spinal metastases. Clin Nucl Med (2014) 0.83
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma. Eur Radiol (2013) 0.83
Evaluation of (68)Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging (2015) 0.83
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer? Clin Nucl Med (2016) 0.83
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer. Nucl Med Commun (2011) 0.82
Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG. Clin Nucl Med (2014) 0.82
Novel use of somatostatin receptor scintigraphy in localization of focal congenital hyperinsulinism: promising but fallible. J Pediatr Endocrinol Metab (2009) 0.81
Proteus syndrome: a case report with bone scintigraphy findings. Diagn Interv Radiol (2013) 0.81
68Ga DOTANOC PET/CT aiding in the diagnosis of von Hippel-Lindau syndrome by detecting cerebellar hemangioblastoma and adrenal pheochromocytoma. Clin Nucl Med (2014) 0.81
Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience. Nucl Med Commun (2013) 0.81
Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence. Clin Nucl Med (2012) 0.81
Cervical and thoracic actinomycosis on (18)F-FDG PET/CT. Clin Nucl Med (2014) 0.81
Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study. Clin Nucl Med (2014) 0.81
18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study. Nucl Med Commun (2014) 0.81
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. Nucl Med Commun (2012) 0.81
Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT. Clin Nucl Med (2013) 0.81
Technetium-99m-L,L-ethylenedicysteine renal scan as a single-modality investigation for the evaluation of renal morphology and function: a comparative study with technetium-99m-dimercaptosuccinic acid. Nucl Med Commun (2004) 0.81
Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard. J Gastroenterol Hepatol (2005) 0.80
Incidental detection of intracranial tuberculomas on (99m)Tc-TRODAT-1 SPECT/CT. Clin Nucl Med (2015) 0.80
Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment. Leuk Lymphoma (2012) 0.80
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor. Eur J Nucl Med Mol Imaging (2014) 0.80
Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma. Q J Nucl Med Mol Imaging (2014) 0.80
A curious case of refractory hypothyroidism due to selective malabsorption of oral thyroxine. Indian J Endocrinol Metab (2012) 0.80
Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary? Clin Nucl Med (2014) 0.80
Production of the PET bone agent (18)F-fluoride ion, simultaneously with (18)F-FDG by a single run of the medical cyclotron with minimal radiation exposure- a novel technique. Hell J Nucl Med (2014) 0.79
Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified? Clin Nucl Med (2014) 0.79
Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings. Clin Nucl Med (2014) 0.79
18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases. Clin Nucl Med (2015) 0.79
Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings. Abdom Imaging (2013) 0.79
Incidental detection of hyperfunctioning thyroid cancer metastases in patients presenting with thyrotoxicosis. Indian J Endocrinol Metab (2012) 0.79
Ribbing disease: Uncommon cause of a common symptom. Indian J Nucl Med (2011) 0.79
Usual and unusual neuroendocrine tumor metastases on (68)Ga-DOTANOC PET/CT: a pictorial review. Clin Nucl Med (2013) 0.78
"Witch's milk" and 99mTc-pertechnetate uptake in neonatal breast tissue: an uncommon but not unexpected finding. Clin Nucl Med (2013) 0.78
Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT? Skeletal Radiol (2011) 0.78
Prospective evaluation of (68)Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative (131)I-whole body scan: comparison with (18)F-FDG PET-CT. Eur J Nucl Med Mol Imaging (2014) 0.78
Comparative analysis of MR imaging, ictal SPECT and EEG in temporal lobe epilepsy: a prospective IAEA multi-center study. Eur J Nucl Med Mol Imaging (2007) 0.78
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy. Nucl Med Commun (2015) 0.77
Comparison of clinical outcome after a fixed dose versus dosimetry-based radioiodine treatment of Graves' disease: Results of a randomized controlled trial in Indian population. Indian J Endocrinol Metab (2014) 0.77
18F-FDG-PET/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up. Nucl Med Rev Cent East Eur (2015) 0.77
Sister Mary Joseph nodule in endometrial carcinoma: detection with FDG PET/CT. Clin Nucl Med (2013) 0.77
SPECT-CT in routine clinical practice: increase in patient radiation dose compared with SPECT alone. Nucl Med Commun (2012) 0.77
18F-FDG PET-CT for Evaluation of Cardiac Angiosarcoma: A Case Report and Review of Literature. Mol Imaging Radionucl Ther (2015) 0.77
Imaging thrombus in cancer patients with FDG PET-CT. Jpn J Radiol (2011) 0.77
Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT. Jpn J Radiol (2012) 0.77
Importance of SPECT/CT in detecting multiple hemangiomas on 99mTc-labeled RBC blood pool scintigraphy. Clin Nucl Med (2015) 0.77
Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma. Clin Nucl Med (2014) 0.77
Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma. Clin Nucl Med (2013) 0.77
Hybrid SPECT-CT with 99mTc-labeled red blood cell in a case of blue rubber bleb nevus syndrome: added value over planar scintigraphy. Diagn Interv Radiol (2012) 0.77
Diagnosis of Men-I Syndrome on (68)Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE. Int J Endocrinol Metab (2012) 0.77
Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience. Indian J Nucl Med (2011) 0.77
Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian J Nucl Med (2013) 0.77
Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy. Indian J Nucl Med (2013) 0.76
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival? Int J Gynecol Cancer (2014) 0.76
Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT. Neuroradiology (2014) 0.76
Discordance in 68Ga-DOTANOC and 177Lu-DOTATATE uptake in diagnostic and post-therapy scans in patients with medullary thyroid cancer-likely reasons. J Cancer Res Ther (2014) 0.76
Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head. Nucl Med Commun (2015) 0.76
Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Eur J Gastroenterol Hepatol (2006) 0.76
Primary rhabdomyosarcoma of pulmonary artery: 18F-FDG PET/CT for detecting recurrence in a rare tumor. Clin Nucl Med (2013) 0.76
68Ga-DOTANOC somatostatin receptor PET-CT imaging in multiple myeloma. Clin Nucl Med (2014) 0.76
Erlotinib-induced cutaneous toxicity: findings on 18F-FDG PET/CT imaging. Clin Nucl Med (2015) 0.75
In Vivo Demonstration of PSMA Expression in Adenocarcinoma Urinary Bladder Using 68Ga-PSMA 11 PET/CT. Clin Nucl Med (2017) 0.75
Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results. Diagn Interv Radiol (2013) 0.75
Characterization of parallel-hole collimator using Monte Carlo Simulation. Indian J Nucl Med (2015) 0.75
Utility of single photon emission computed tomography/CT hybrid imaging over planar I-131 whole body scans in detection of adrenal metastases in differentiated thyroid cancer. Indian J Endocrinol Metab (2013) 0.75
Graves' disease in a Down's syndrome patient responds well to radioiodine rather than antithyroid drugs. J Pediatr Endocrinol Metab (2011) 0.75
Positive (68)Ga-DOTANOC PET/CT with negative (131)I- metaiodobenzylguanidine scan in a case of Glomus Jugulare. Indian J Endocrinol Metab (2013) 0.75
Association of non-traumatic complex regional pain syndrome with adenocarcinoma lung on 99mTc-MDP bone scan. Indian J Nucl Med (2012) 0.75
Post meningitis subdural hygroma: Anatomical and functional evaluation with (99m)Tc-ehylene cysteine dimer single photon emission tomography/computed tomography. Indian J Nucl Med (2013) 0.75